HBsAG combined with the immunostimulatory sequence 1018 ISS can provide effective and lasting seroprotection

By  

Inpharma, Vol. 1, Iss. 1608, 2007-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Hepatitis-B Surface Antigen (HBsAg) Powder Formulation: Process and Stability Assessment

By  

Current Drug Delivery, Vol. 4, Iss. 1, 2007-01 ,pp. : 57-67

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibiting the Secretion of Hepatitis B Surface Antigen (HBsAg) to Treat Hepatitis B Infection- a Review

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 17, Iss. 1, 2017-03 ,pp. : 24-35

Bentham Science Publishers

Access to resources Recommend Favorite

Antineoplastics: Fatal reactivation of hepatitis B virus infection in a HBsAg-negative and anti-HBc-positive patient: case report

By  

Reactions Weekly, Vol. 1, Iss. 1273, 2009-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Formulation, characterization and optimization of Hepatitis B surface antigen (HBsAg)-loaded chitosan microspheres for oral delivery

By Premaletha K.   Licy C.D.   Jose Sajan   Saraladevi A.   Shirwaikar Annie   Shirwaikar Arun  

Pharmaceutical Development and Technology, Vol. 17, Iss. 2, 2012-04 ,pp. : 251-258

Informa Healthcare

Access to resources Recommend Favorite